Application 220493
- Type
- ANDA
- Sponsor
- ANTHEA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.25% | No | No |
| 002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.5% | No | No |
| 003 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.75% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220493-001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | |
| A220493-002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | |
| A220493-003 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220493-001 | AP |
| A220493-002 | AP |
| A220493-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220493-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220493-002 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220493-003 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENSORCAINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb | 2023-04-30 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | a60303c2-5217-41db-855b-83fa2a749da2 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175 | 2022-08-17 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | 3eefbefe-78ae-4f2d-9be6-3f79eadcff86 | 2020-04-09 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.